Literature DB >> 10486429

A compartmental absorption and transit model for estimating oral drug absorption.

L X Yu1, G L Amidon.   

Abstract

This report describes a compartmental absorption and transit model to estimate the fraction of dose absorbed and the rate of drug absorption for passively transported drugs in immediate release products. The model considers simultaneous small intestinal transit flow and drug absorption. Both analytical and numerical methods were utilized to solve the model equations. It was found that the fraction of dose absorbed can be estimated by F(a) = 1-(1+0.54 P(eff))(-7), where P(eff) is the human effective permeability in cm/h. A good correlation was found between the fraction of dose absorbed and the effective permeability for ten drugs covering a wide range of absorption characteristics. The model was able to explain the oral plasma concentration profiles of atenolol.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10486429     DOI: 10.1016/s0378-5173(99)00147-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  81 in total

1.  Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugs.

Authors:  L X Yu; C D Ellison; D P Conner; L J Lesko; A S Hussain
Journal:  AAPS PharmSci       Date:  2001

2.  In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.

Authors:  Bei Yang; David E Smith
Journal:  Pharm Res       Date:  2017-08-02       Impact factor: 4.200

3.  A physiologic model for simulating gastrointestinal flow and drug absorption in rats.

Authors:  Stefan Willmann; Walter Schmitt; Jörg Keldenich; Jennifer B Dressman
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 4.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model.

Authors:  Emilie Hénin; Martin Bergstrand; Joseph F Standing; Mats O Karlsson
Journal:  AAPS J       Date:  2012-06       Impact factor: 4.009

6.  In vitro-in vivo correlations: tricks and traps.

Authors:  J-M Cardot; B M Davit
Journal:  AAPS J       Date:  2012-05-01       Impact factor: 4.009

7.  Use of partial AUC to demonstrate bioequivalence of Zolpidem Tartrate Extended Release formulations.

Authors:  Robert A Lionberger; Andre S Raw; Stephanie H Kim; Xinyuan Zhang; Lawrence X Yu
Journal:  Pharm Res       Date:  2012-01-26       Impact factor: 4.200

8.  A novel strategy for physiologically based predictions of human pharmacokinetics.

Authors:  Hannah M Jones; Neil Parrott; Karin Jorga; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

9.  Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

Authors:  Hannah M Jones; Neil Parrott; Gerd Ohlenbusch; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 10.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.